.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Professor Luis Miguel Ortega Mora

Madrid / ES

Complutense University of Madrid

Weitere Beteiligungen

Mo, 27.05.2024
Poster presentation
P055
Genotyping of European Toxoplasma gondii strains by a new high-resolution next-generation sequencing-based method
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Mo, 27.05.2024
Poster presentation
P049
In vitro models using target ovine cell lines to evaluate the Toxoplasma gondii phenotype
Host-Parasite Interaction & Signalling
Mo, 27.05.2024
Poster presentation
P047
Treatment with BKI-1748 after Toxoplasma gondii systemic dissemination in experimentally infected sheep significantly improves clinical outcome and prevents congenital infection
Metabolism, Biochemistry & Drug Development
Mo, 27.05.2024
Poster presentation
P063
Serological and molecular survey of Toxoplasma gondii infection in wild carnivores of the Iberian Peninsula
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Di, 28.05.2024
14:45 – 15:00 12 Min. 3 Min.
Oral presentation
T49
Usefulness of serotyping tools in Toxoplasma gondii infections in sheep and pigs
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Di, 28.05.2024
Poster presentation
P036
Activity and efficacy of the bumped kinase inhibitor BKI-1708 in vitro and in non-pregnant and pregnant toxoplasmosis and neosporosis mouse models
Metabolism, Biochemistry & Drug Development
Di, 28.05.2024
Poster presentation
P080
Short-term in vitro culture adaptation of Toxoplasma gondii archetypal II and III field isolates induces relevant changes in the transcriptomic profile
Stage Conversion & Developmental Biology